Table 1.
Skin appendage | Type and source of cells/tissues | Passage | Culture conditions | Study model | Refs. |
---|---|---|---|---|---|
Sweat glands | Autologous SG‐derived progenitors | NS | NS | In vivo; lineage tracing with RosaLacZ or RosaYFP reporter mice | [27a] |
Adult human bone marrow‐derived MSCs | 3 | Monolayers | In vitro; direct coculture of human SCs with heat‐shocked confluence human SG cells | [29] | |
SG germ cells | NS | NS | In vivo; transgenic expression of the mouse EDA‐A1 isoform in tabby (EDA‐less) males | [33] | |
Adult human bone marrow‐derived MSCs | 2–3 | Cocultured with human SG cells |
In vivo; implanting cocultured MSCs in athymic BALB/c nude mice Clinical trial; transplantation of transdifferentiated MSCs |
[34] | |
Human umbilical cord‐derived MSCs | 3–5 |
Basic SG medium‐plus conditioned heat‐shock SG medium (9:1) Keratinocyte growth factor |
In vitro; culturing human SCs in the media supplemented by the growth factor In vivo; transplanting SG cells differentiated from human SCs into SCID mouse burn model |
[32] | |
Human bone marrow‐derived MSCs transfected with ectodysplasin | NS | NS | In vivo; transplanting human SCs into the injured areas of burn animal models | [35] | |
Sebaceous glands | Bulge cells in adolescent hr mice | NS | NS | In vivo; treating hr mice with and without topical dioxin | [36] |
Adult bulge SCs | NS | Dulbecco's Vogt modified Eagle | In vivo; implanting fragments of bulges from vibrissal follicles of adult mice onto the back of mouse embryos | [19g] | |
EGFP‐high/α6‐integrin+ cells from Krt1‐15‐EGFP; ROSA26 skin mice | NS | Cell suspension | In vivo; combining the bulge SCs with epithelial and dermal cells and injected subcutaneously or placed in tracheas and then implanted subcutaneously into CB‐17 Icr‐scid/scid mice | [37] | |
Bulge cells from adult K14‐GFP‐actin mice | NS | Cell suspension | In vivo; combining the bulge cells with epithelial and dermal cells and implanted onto the back of nude mice | [38] | |
Epidermal cells from Blimp1GFP mice (Blimp1+ sebaceous gland progenitor cells) | NS | Cell suspension | In vivo; combining the bulge cells with epithelial and dermal cells and implanted onto the back of nude mice | [39] | |
Epidermal cells from transgenic mice (Lrig1+ SCs) | 1 & 5 | Cell suspension | In vivo; combining the SCs with epithelial and dermal cells and implanted onto the back of nude mice | [40] | |
Epidermal cells from intercrossed mice (Lrg6+ SCs) at the isthmus | NS | NS | In vivo; intercrossing Lgr6‐EGFP‐Ires‐CreERT2 to the Cre reporter R26R‐LacZ mice | [41] | |
Adult bulge SCs from transgenic mice (Sox9+ SCs) in the upper ORS | NS | NS | In vivo; crossing Sox9‐IRES‐Cre mice to ROSA26Flox‐Stop‐Flox‐βgeo (R26R) mice | [42] | |
HF progenitor cells from mouse tail epidermis (Lrg6+ SCs) | NS | NS | In vivo; C57Bl/6 mice between E15.5 and P2 were studied using immunostaining | [43] | |
HF SCs from human facial skin (K15+ cells) | NS | NS | In vivo; grafting human facial skin specimens onto SCID mice | [44] | |
Human neonatal foreskin Kcs | 3 | TSC2‐null Fb‐like cells incorporated into collagen and overlaid with Kcs | In vivo; grafting composites onto immunodeficient mice | [45] | |
GFP‐positive bone marrow cells from adult mice | NS | Cell suspension | In vivo; transplanting in a mixture of embryonic mouse epidermal and dermal cells on the backs of nude mice | [46] | |
Mouse bone marrow‐derived allogeneic mesenchymal stromal cells | 1 | Cell suspension | In vivo; injecting intradermally in the periphery of the excisional wound in NOD mice | [47] | |
Porcine bone marrow‐derived MSCs | NS | NS | In vivo; engrafting to porcine skin | [48] | |
MSCs from Wharton's Jelly of the human umbilical cord | NS | Cell suspension | In vivo; (co)transplanting MSCs and/or skin microparticle (autologous) in C57BL/6 mice with a degree III deep burning wound | [49] |